Polatuzumab-vedotin

13/06/2019 13 min
Polatuzumab-vedotin

Listen "Polatuzumab-vedotin"

Episode Synopsis

A newly approved drug for relapsed/refractory diffuse large B-cell lymphoma is discussed as well as PBR.